RE:RE:My rough math with assumptions I think, reverse split would be a bad idea. Once we get BTD, AA will follow very soon. With AA, I believe we can go directly to commercial stage pending that the treatment meets the pre-set FDA guidelines within a pre-set time frame. That would be a more prudent way to go...